||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Netscientific Share Discussion Threads
Showing 651 to 674 of 675 messages
|No - invest and let the story unfold. Commercialisation of nascent projects is not some swift overnight process|
|hold and hope then eh yasx?|
|Or, alternatively, the various assets within the portfolio group receive external funding to take them to the point of commercialisation. Be it noted that some of these are now at the stage of commercialisation so sooner or later revenues will start appearing, though I accept the cost base is too high and should be reduced.|
|£1 million a month you say......piggies having a good feed then.....what happens in a few months when its nearly all gobbled up?
likely pawing over the confetti machine instruction handbook as we post.|
Plucking figures out of thin air is a strategy for novice punters. Any reference to facts to support your view? No, thought not.
Given last reported cash (some 8 months ago) indicated cash balance of £15.8 mln, I do not see how you come up with that assessment. Even allowing for £1mln spend per month, there is still a healthy cash pile and all of the businesses have received collective funding from external sources in excess of £15mln.
This is one for the long term, and the £5 target is intact. This is dwindling on small volumes because it is thinly traded - I see no sign of a significant holder selling, and the free float is tiny thus moves seem exaggerated.|
|15m cap looks about right here.|
|selling at 50 now.....|
|I retain my holding - a nascent play in this sector is an investment not a trade. Those who are worried cann sell out. I am not.
As for TRIN, well, you are following Zengas. Why don't you ask him who alerted him to the likely tremendous value at 2p, and, I for one remained in until yesterday at over 18p, all laid out every step of the way. You only arrived at TRIN since you follow me around.|
|There is nothing to say here, no reports, no management meetings, its all disappointing to followers.Meanwhile, TRIN up 25% since I flagged it here and more to come - Research Zengas and Big Fella posts on that bb. Do some research and think for yourselves, investors here are trapped in an illiquid stock that slowly falls as cash disappearsI stand by a fund raising or diluting deal this year.|
|Yasmin - all you have done here is shown yourself to be no better than the ramping halfwits you see on other threads.Good luck with this "investment". Looks more likely to see 30p than a quid.|
beeks of arabia
|selling @55p now....|
|Heading to 40p sometime imo.|
I thought the bottom had been called here:
"yasX 16 Feb '17 - 01:37 - 632 of 641 1 0
Meanwhile NSCI holding firm the past few days - looks like Chewin was advising selling yet another stock at the very bottom. He really is a perfect contrarian signal."
Anyone investing here must be looking years out, the money is dead right now, who would buy a chart like that until there is a turnaround - go where the money is (e.g the market is keen on TRIN ).|
|An unacceptable share price performance.
Come on Netscientific , lets do the jiggle jiggle!|
|Where have all the buyers gone.|
|Yep, that's the long and short of your contributions.
Yas - It would be good to get some further guidance on this one. When do you think this will add to the bottom line and are they more likely to sell before that point?|
beeks of arabia
beeks of arabia
|22 February 2017
("NetScientific" or the "Company" or the "Group")
Vortex Biosciences Announces Commercial Launch of Fully Automated Liquid Biopsy System for
London, UK - 22 February 2017 - NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that its portfolio company, Vortex Biosciences, has begun the commercial launch of the VTX1 Liquid Biopsy System; its fully automated benchtop system for collecting intact circulating tumour cells (CTCs) that are shed by tumours, using patented innovative microfluidic technology.
NetScientific shareholding in Vortex is 95% and as of 31 December 2016, the Group has invested GBP13.1 million. Grant funding received to develop the underlying technology, prior to Vortex's formation, was GBP1.6 million.
Commenting on the news, François R. Martelet, Chief Executive Officer of NetScientific, said: "We are pleased to announce the commercial launch of Vortex's VTX-1 Liquid Biopsy System into research labs. We believe the technology has several key advantages over current approaches to CTC isolation and has the potential to make a meaningful impact on cancer research and assist the development of innovative diagnostics and therapeutics. The commercial launch is a critical milestone for Vortex and brings our portfolio company closer to significant value creation."|
|However i bet my dad can fight your dad!Pathetic. Give it a rest you two.|
beeks of arabia
No doubt you know, as I posted nearly all my trades from August last year to December as they happened on advfn - they are there for all to see - posted upfront - so you can see where and how I made profits.
I'm contrarian, unlike you who follows Zengas, I call it out the way I see it.
I'm honest enough to say when I make mistakes, you of course never make mistakes.
BTW, I don't recall ever calling this out as a sell as I'm not qualified to give financial advice - if I did however, it might have saved horrendous losses for some.|
|Meanwhile NSCI holding firm the past few days - looks like Chewin was advising selling yet another stock at the very bottom. He really is a perfect contrarian signal.|